Cargando…

Complex interactions of cellular players in chronic Graft-versus-Host Disease

Chronic Graft-versus-Host Disease is a life-threatening inflammatory condition that affects many patients after allogeneic hematopoietic stem cell transplantation. Although we have made substantial progress in understanding disease pathogenesis and the role of specific immune cell subsets, treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gail, Laura Marie, Schell, Kimberly Julia, Łacina, Piotr, Strobl, Johanna, Bolton, Steven J., Steinbakk Ulriksen, Emilie, Bogunia-Kubik, Katarzyna, Greinix, Hildegard, Crossland, Rachel Emily, Inngjerdingen, Marit, Stary, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332803/ https://www.ncbi.nlm.nih.gov/pubmed/37435079 http://dx.doi.org/10.3389/fimmu.2023.1199422

Ejemplares similares

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors
por: Wielińska, Joanna, et al.
Publicado: (2021)

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
por: Doglio, Matteo, et al.
Publicado: (2022)

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
por: Łacina, Piotr, et al.
Publicado: (2018)

TERT—Regulation and Roles in Cancer Formation
por: Dratwa, Marta, et al.
Publicado: (2020)

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018)

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022)

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
por: Dratwa, Marta, et al.
Publicado: (2021)

Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
por: Dratwa, Marta, et al.
Publicado: (2023)

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
por: Butrym, Aleksandra, et al.
Publicado: (2017)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023)

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia
por: Łacina, Piotr, et al.
Publicado: (2022)

Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation
por: Partanen, Jukka, et al.
Publicado: (2020)

Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia
por: Wicherska-Pawłowska, Katarzyna, et al.
Publicado: (2022)

Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat
por: Jalapothu, Dasaradha, et al.
Publicado: (2016)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Juric, Mateja Kralj, et al.
Publicado: (2017)

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
por: Perovic, Vladimir, et al.
Publicado: (2022)

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64
por: Iwaszko, Milena, et al.
Publicado: (2018)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

P1578: SERUM EXTRACELLULAR VESICLE MIRNA PROFILING TO DETERMINE EXTRACORPOREAL PHOTOPHERESIS TREATMENT RESPONSE IN GRAFT VERSUS HOST DISEASE PATIENTS
por: Schell, Kimberly, et al.
Publicado: (2023)

Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
por: Milosevic, Emina, et al.
Publicado: (2022)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2021)

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
por: Saas, Philippe, et al.
Publicado: (2022)

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016)

P1255: EXTRACELLULAR VESICLES CONTRIBUTE TO THE MECHANISM OF ACTION OF AUTOLOGOUS SERUM EYE DROPS AS A TREATMENT MODALITY FOR CHRONIC GRAFT VERSUS HOST DISEASE
por: Bogdanic, Darija, et al.
Publicado: (2023)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
por: Siemaszko, Jagoda, et al.
Publicado: (2021)

Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis
por: Gębura, Katarzyna, et al.
Publicado: (2017)

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
por: Lelas, Antonela, et al.
Publicado: (2021)

Searching for New Genetic Biomarkers of Axial Spondyloarthritis
por: Bugaj, Bartosz, et al.
Publicado: (2022)

VDR Polymorphic Variants Are Related to Improvements in CRP and Disease Activity in Patients with Axial Spondyloarthritis That Undergo Anti-TNF Treatment
por: Bugaj, Bartosz, et al.
Publicado: (2022)

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
por: Sokolik, Renata, et al.
Publicado: (2021)

The Influence of Comorbidities on Chemokine and Cytokine Profile in Obstructive Sleep Apnea Patients: Preliminary Results
por: Chaszczewska-Markowska, Monika, et al.
Publicado: (2023)

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2014)

New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kipemhhj69lsqnmtdrd3plidht